Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Partek Inc And Europe And Asia"

18:08 EDT 19th April 2014 | BioPortfolio

Matching Channels

Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...




The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...

Yellow Fever

Yellow fever is an acute viral hemorrhagic disease. The virus is a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. The yellow fever virus is transmitted by the bite o...


Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

Matching News

HIV infections up in Europe and Central Asia

HIV infections in Europe and Central Asia increased by eight percent in 2012 compared to a year earlier, the European Centre for Disease Prevention and Control announced Wednesday.

McDonald's January Global Comps Rise 1.2% On Europe, Asia Sales, Tops Estimates

OAK BROOK (dpa-AFX) - Fast food giant McDonald's Corp. (MCD) announced Monday that sales at established stores grew 1.2 percent in January on strong Europe and Asia sales, while sales were negativ...

Five-year Trend Shows U.S. R&D Spending Flowing to Asia

A startling report in The New England Journal of Medicine shows U.S. industry investment in biomedical research and development falling off a cliff over the past five years – and reappearing in Asia...

Global biomedical R&D investment shifts towards Asia

Investment in biomedical R&D, both publicly funded and by industry, rose across Asia and Oceania by nearly 21% from 2007-12, while corresponding investments in the US, Canada and Europe declined by 7%...

Life Technologies' Ion AmpliSeq' Exome Certified Service Provider Program Adds 12 New Members in US, Europe and Asia Pacific

CARLSBAD, Calif., Dec. 20, 2013 /PRNewswire/ --Life Technologies Corporation(NASDAQ: LIFE) today announced that five new American, five European and two Asia Pacific sites joined the Ion AmpliSeq'...

HIV infections up by 8% across Europe

More testing and better treatment coverage recommended According to new data issued today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, more...

Meeting Calls For Asia-Wide Drug Approval System To Prevent Pandemics

A new report calls for creation of an Asia-wide drug-approval system the likes of those in Europe and the U.S. as one way to combat an increasing threat of communicable diseases in the region.

HIV Cases Are Increasing in Eastern Europe and Central Asia

Although AIDS cases have decreased steadily in Western Europe in the last several years, the number of people newly diagnosed with AIDS is increasing in the eastern part of the World Health Organizati...

Matching PubMed Articles

Sea-Level Rise and Coastal Wetlands.

This paper seeks to quantify the impact of a 1-m sea-level rise on coastal wetlands in 86 developing countries and territories. It is found that approximately 68 % of coastal wetlands in these countr...

Advancing human rights in patient care through higher education in Eastern Europe and Central Asia.

Background: In Eastern Europe and Central Asia, for society's most marginalized people, health systems are too often places of violations of basic rights, rather than of treatment and care. At the sam...

Erratum: Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia Corrigendum.

[This corrects the article on p. 39 in vol. 5.].

Guillain-Barre syndrome in Asia.

Over the past 20 years, the most notable advance in understanding Guillain-Barré syndrome (GBS) has been the identification of an axonal variant. This advance arose chiefly through studies undertaken...

Advancing human rights in patient care through strategic litigation: Challenging medical confidentiality issues in countries in transition.

The concept of human rights in patient care offers a framework, relevant to both patients and providers, for identifying and addressing human rights violations within a state's health system. While a...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement